PerkinElmer

Target Discovery

OF

Accurately identify disease-relevant targets and thoroughly validate each one to ensure downstream success in your drug development.

  • Our phenotype-oriented target identification and validation techniques enable direct correlations between genetic alterations and disease phenotypes, reducing the risk of failures at early stages
  • When combined, our in vitro and in vivo methods provide the most accurate prediction of target relevance in human disease
  • Cellular imaging for in vitro target validation
  • In vivo imaging for target discovery
  • Tissue imaging for ex vivo target validation
  • Allow for capture and analysis of all experimental data via our electronic laboratory notebook and data analytic solutions to transform big data into bigger results

Products & Services (236)
Filters:

Filters :

Product Type
  • Accessories (37)
  • Consumables (4)
  • Instruments (17)
  • Reagents (174)
  • Software and Informatics (4)
Assay Target
  • and three open channels (1)
  • CD20 (3)
  • CD4 (4)
  • CD45RO (1)
  • CD68 (2)
  • CD8 (4)
  • FOXP3 (2)
  • panCK (2)
Target Species
  • Human (4)
Application
  • Drug Discovery & Development (53)
  • Immunohistochemistry (IHC) (25)
  • In situ hybridization (ISH) (25)
  • Mobility Shift (36)
Therapeutic Area
  • Angiogenesis (5)
  • Cancer (2)
  • Cardiovascular (19)
  • CNS & Neurologic (17)
  • Inflammation (17)
  • Metabolic Disorders (16)
  • Pain (6)
Product Brand Name
  • Ancillary Products (2)
  • EnSight (1)
  • EnSpire (2)
  • EnVision (2)
  • FMT (3)
  • G-Platform (2)
  • IVIS (6)
  • LabChip EZ Reader (49)
  • NEN Radiochemicals (79)
  • Opal (6)
  • Opera Phenix (1)
  • Operetta (29)
  • Operetta CLS AND Opera Phenix (7)
  • Quantum (1)
  • TSA (12)
  • TSA Plus (14)
  • Victor (1)
  • ViewLux (1)
Detection Method
  • Absorbance (4)
  • Alpha (2)
  • Chromogenic (6)
  • Fluorescence (36)
  • Fluorescence Polarization (3)
  • Image-based Cytometry (1)
  • Luminescence (4)
  • MSI (6)
  • Radiometric (91)
  • Time-Resolved Fluorescence (TRF) (4)
  • Transmission (1)
Receptor Type
  • Free Fatty Acid (11)
  • Histamine (6)
  • Inositol Triphosphate (1)
  • IRK channels (3)
  • Leukotriene (1)
  • Nicotinic (2)
  • Organic zwitterions/cation transporters (OCTN) (2)
  • Phosphatidylcholine Transfer Protein (PCTP) (2)
  • Prostanoid (7)
  • Retinoic Acid Receptors (1)
  • TRP Channels (3)
Sample Type
  • Enzyme (38)
Radioisotope
  • C-14 (39)
  • H-3 (53)
Radionuclide
  • 14C (38)
  • 3H (53)
Volume Capacity
  • 150 µL (2)
Fluorophore
  • Coumarin (1)
  • Cy3 (8)
  • Cy3.5 (1)
  • Cy5 (4)
  • Cy5.5 (1)
  • Fluorescein (6)
  • Opal 520 (5)
  • Opal 540 (3)
  • Opal 570 (4)
  • Opal 570 and Opal 690 (1)
  • Opal 620 (3)
  • Opal 650 (3)
  • Opal 670 (1)
  • Opal 690 (3)
  • TMR (5)
Label Position
  • Nominally Labeled (17)
  • Specifically Labeled (58)
  • Uniformly Labeled (16)
Buffer
  • Aqueous (1)
  • Ethanol : water (1)
  • Ethanol:water (1)
  • HCl (1)
  • Sulfuric acid:ethanol (2)
Automation Compatible
  • No (4)
  • Yes (6)
Concentration
  • 0.05 mCi/mL (3)
  • 0.1 mCi/mL (9)
  • 0.55 mCi/mL (2)
  • 1 mCi/mL (23)
  • 1.0 - 10 mCi/mL (7)
  • 5 mCi/mL (1)
  • <1.0 mCi/mL (20)
  • <1.0 µCi/mL (1)
Format
  • Slides (25)
Imaging Modality
  • High Content (1)
  • microCT Imaging (2)
  • Optical Imaging (9)
  • PET Imaging (2)
Length
  • 41-50 (4)
  • 51-100 (7)
  • 101-200 (1)
  • 901-1000 (1)
Maximum Temperature (Celsius)
  • 40-50 (2)
  • 50-60 (2)
Model Compatible With
  • Operetta (30)
  • Operetta CLS AND Opera Phenix (8)
Volume
  • 0-50 (31)
  • 51-100 (1)
  • 201-250 (20)

1-12 of 236 Products & Services

Sort by

  • IVIS SpectrumCT 2D/3D Optical/CT In Vivo Imaging System

    IVIS SpectrumCT In Vivo Imaging System

    The IVIS® SpectumCT preclinical in vivo imaging system expands upon the versatility of the IVIS Spectrum by offering 2D and 3D imaging capabilities but includes integrated low-dose microCT ideal for longitudinal studies. The system provides researchers with greater insights into complex biological systems by enabling simultaneous molecular and anatomical non-invasive imaging in animal models.
  • IVIS Spectrum In Vivo Imaging System

    IVIS Spectrum In Vivo Imaging System

    The IVIS® Spectrum in vivo imaging system combines 2D optical and 3D optical tomography in one platform. The system uses leading optical technology for preclinical imaging research and development ideal for non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals.
  • FMT In Vivo Imaging Instrument

    FMT 2000 In Vivo Imaging System

    The FMT 2000 is a workhorse 3D fluorescence tomographic system with the ability to quantitate up to two fluorophores simultaneously.
  • VictorX_ImageA_320px

    VICTOR Multilabel Plate Reader

    The VICTOR Multilabel plate reader has been replaced by the VICTOR Nivo multimode plate reader. Please contact your local representative for further information, or visit the VICTOR Nivo product page (Part Number - HH35000500).
  • Quantum GX2 microCT imaging system

    Quantum GX2 microCT Imaging System

    Image beyond bone – into oncology, cardiovascular and pulmonary diseases, and much more, with the Quantum GX2 microCT imaging system. With the Quantum GX2, flexibility is key. Combining the ability to perform high speed, low dose scans, ideal for longitudinal studies, across multiple species (mice, rats, rabbits) with high resolution ex vivo scanning, the Quantum GX2 microCT imaging system offers the flexibility and performance you need to not just image, but further understand your disease models.
  • FMT In Vivo Imaging Instrument

    FMT 4000 In Vivo Imaging System

    The FMT 4000 fluorescence tomography imaging system provides the greatest utility of the FMT Systems with the ability to quantitate up to four fluorophores simultaneously. It comes with four excitation laser channels (635, 680, 750, & 790 nm).
  • FMT In Vivo Imaging Instrument

    FMT 1000 In Vivo Imaging System

    The FMT® 1000 is an entry level 3D fluorescence tomographic system with the ability to quantitate a single fluorophore at a time.
  • EnSight Multimode Plate Reader

    EnSight Multimode Plate Reader

    The EnSight multimode plate reader combines labeled & image-based cytometry technologies in a single benchtop platform. Imaging & online data analysis is fast: a 384-well plate can be imaged in less than 5 mins. The system’s modular design, combined with workflow-based Kaleido data acquisition & analysis software, gives a truly versatile plate reader that gets users productive quickly.
  • ViewLux uHTS Microplate Imager

    ViewLux uHTS Microplate Imager

    The ViewLux® is the gold standard, ultra high-speed microplate imager, ideal for high throughput screening of compound libraries requiring the ultimate in speed, reliability and high quality data.

    The ViewLux uHTS microplate imager is available outside the EU. Please contact your local representative to discuss alternative products.

  • G8 PET/CT benchtop scanner for preclinical imaging research

    G8 PET/CT Preclinical Imaging System

    Ultrasensitive and fast multimodal preclinical PET/CT imaging at your benchtop. The G-Platform offers Full Solutions for PET Imaging  and includes the G4 and G8 imaging systems.
  • IVIS Spectrum In Vivo Imaging System

    IVIS SpectrumBL High-Throughput In Vivo Optical Imaging System

    The IVIS® SpectrumBL is an advanced high-throughput 2D and 3D optical imaging system designed to improve quantitative outcomes of bioluminescent, chemiluminescent and Cerenkov in vivo imaging.
  • IVIS Lumina HT High Throughput Benchtop 2D Optical Imaging System

    IVIS Lumina LT In Vivo Imaging System

    The IVIS® Lumina LT Series III pre-clinical in vivo imaging system offers the industries most sensitive benchtop platform at an entry level price.
  • Jump to:
Business Insights (18)
Filters:

Filters :

Resource Library
  • Application Note (14)
  • Poster (3)
  • White Paper (1)

1-12 of 18 Business Insights

Sort by

  • White Paper

    Streamlining Materials Innovation Processes with Electronic Lab Notebook (ELN) and Data Analytics for Optimum Efficiency

    This paper explores the numerous challenges materials scientists and engineers face, from the time it takes to bring new materials to market to the difficulties delivering suitable formulations and testing against specified criteria, and how those can be resolved.

  • Application Note

    Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

    Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection. This application note investigates the use of three fluorescent imaging probes, to detect and monitor vascular leak and inflammation in preclinical mouse breast cancer models.

  • Application Note

    Stem Cell Research and Regenerative Medicine

    With the potential to treat a wide range of disease, from organ damage to congenital defects, stem cell research and tissue engineering form the underlying basis of regenerative medicine. Significant advances in the science of skin regeneration, for example, have now made it possible to develop and grow artificial skin grafts in a lab for treatment of burn victims. Other therapeutic applications include the use of stem cells to treat and repair central nervous system diseases such as ischemia and cerebral palsy, cardiovascular diseases, as well as autoimmune diseases including type I diabetes.

  • Application Note

    Phenotypic Analysis of Hypertrophy in Human iPSC-Derived Cardiomyocytes

    Learn how a phenotypic screening assay to study time-dependent effects of endothelin-1-induced hypertrophy was set up using human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Learn how: The Opera Phenix system has been applied in the field of neurodegenerative diseases. In this assay, the Opera Phenix system is 4 times faster than the previous Opera® system. Primary neuron morphology is analyzed in a straightforward approach using Harmony software. Careful assay optimization can increase throughput, and minimize the data burden, without compromising assay performance.

  • Application Note

    Distinguishing Cell Types by Phenotypic Profiling of the Nucleus

    The promise of high-content screening is the acceleration of discovery by extracting as much relevant information as possible from cells. Nevertheless, a large percentage of high-content screens analyze only a small number of image-based properties. As a result, valuable information from precious cells and disease models is not utilized. As nearly all screening approaches require a nuclear counterstain such as Hoechst to facilitate segmentation, phenotypic profiling of the nuclei can offer new and additional perspectives on assays at no extra cost.

  • Application Note

    Phenotypic Profiling of Autophagy using the Opera Phenix High-Content Screening System

    Cells constantly sense their environment and their response is a spatio-temporal summation of all signals. To maintain physiological stability, cells need to adjust to environmental changes, a process called homeostasis. One of the most important processes involved in maintaining homeostasis is autophagy, and its significance was recognized by the award of the Nobel Prize for Physiology in 2016 to Yoshinori Ohsumi for the discovery of its underlying mechanisms. Although this is not fully understood, it is believed that autophagy can prevent tumor development by degrading, for example, damaged organelles and protein aggregates.

  • Application Note

    NIR Fluorescent Cell Labeling for In Vivo Cell Tracking (VivoTrack 680)

    Fluorescent dyes have been used for many years to label cells for microscopy studies, and a variety of dyes in the visible fluorescence spectrum are available to label different cellular compartments and organelles. Efficient delivery of the fluorophore to the cell without excessively modifying surface proteins or perturbing cell function is the major biotechnological challenge. In addition, researchers have taken on the challenge of in vivo imaging, focusing on near infrared (NIR) dyes that fluoresce in a spectral region better suited for in vivo imaging due to reduced background and higher tissue penetration.

  • Application Note

    Contrast-enhanced Imaging of Vasculature and Soft Tissues Using the Quantum GX MicroCT System

    X-ray CT imaging is commonly used for skeletal imaging as bones are densely mineralized tissues with excellent x-ray attenuation properties. In contrast, soft, less dense tissues often prove to be challenging to image due to their lack of sufficient tissue density. Soft tissues such as muscle, blood vessels and internal organs share similar x-ray attenuation characteristics and are not distinguishable under typical CT settings. In order to introduce density that would improve soft tissue contrast, several contrast agents have been developed for use in clinical and preclinical settings. This application note outlines the use of iodine and nanoparticle-based contrast agents for imaging soft tissues and vasculature in various organs using the Quantum GX to gain further insights into disease and therapeutic response.

  • Application Note

    Imaging Bile Canaliculi in 3D Liver Microtissues using the Opera Phenix HCS System

    Analyzing transport of biliary metabolites is essential to predict pharmacokinetics and hepatotoxicity during drug development. A functional impairment of hepatobilary transporters, such as bile salt export pump (BSEP) and multidrug resistance-associated protein 2 (MRP-2), is strongly associated with an increased risk of cholestatic liver injury. Here, we describe a 3D high-content screening assay to study hepatobiliary transporter function in InSphero human liver microtissues. Confocal imaging and automated image analysis were used to quantify BSEP and MRP-2-mediated efflux of fluorescent substrates into bile canaliculi.

  • Application Note

    Preclinical Fluorescence Imaging of Cancer Metastasis to the Lung and Response to Therapy

    Quantitative pre-clinical fluorescence imaging transcends the boundaries of traditional optical imaging of biological structures and physiology by providing information at the molecular level about disease states and therapeutic response. Fluorescent Pre-clinical Imaging Agents and FMT® (Fluorescence Molecular Tomography) Quantitative Pre-clinical Imaging Systems represent powerful tools for research and drug development in the imaging of biological processes and pharmaceutical activity in living animals.

  • Application Note

    Multiplex 2D Imaging of NIR Molecular Imaging Agents on the IVIS SpectrumCT and FMT 4000

    Epifluorescence (2D) imaging of superficially implanted mouse tumor xenograft models offers a fast and simple method for assessing tumor progression or response to therapy. This approach for tumor assessment requires the use of near infrared (NIR) imaging agents specific for different aspects of tumor biology, and this Application Note highlights the ease and utility of multiplex NIR fluorescence imaging to characterize the complex biology within tumors growing in a living mouse.

  • Application Note

    Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

    Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting the importance of early integration of liver safety assessment in the drug development process. A technical approach for in vivo toxicology determination was developed using Acetaminophen (APAP), a commonly used over-the-counter analgesic and antipyretic drug, to induce acute hepatocellular liver injury.

  • Jump to: